Application of Machine Learning Methods for the Development of Antidiabetic Drugs

Juanjuan Zhao,Pengcheng Xu,Xiujuan Liu,Xiaobo Ji,Minjie Li,Sooranna Dev,Xiaosheng Qu,Wei Lu,Bing Niu
DOI: https://doi.org/10.2174/1381612827666210622104428
IF: 3.31
2022-01-01
Current Pharmaceutical Design
Abstract:Diabetes is a chronic non-communicable disease caused by several different routes, which has attracted increasing attention. In order to speed up the development of new selective drugs, machine learning (ML) technology has been applied in the process of diabetes drug development and opens up a new blueprint for drug design. This review provides a comprehensive portrayal of the application of ML in antidiabetic drug use.
What problem does this paper attempt to address?